Permanently Discontinued

ACT DORZOTIMOLOL

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ACT DORZOTIMOLOL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ACT DORZOTIMOLOL 5MG 20MG has been permanently discontinued (last updated May 28, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ACT DORZOTIMOLOL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength5MG 20MG

Last updated2025-05-28

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02404389

Strength

5MG 20MG

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

TIMOLOL DORZOLAMIDE

Tier

Unrated

Last Updated

2025-05-28

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

200MG · DIN 02420163

100MG · DIN 02420155